Dr Jordheim is a PharmD/PhD, associate professor at the School of Pharmacy and member of the Oncopharmacology team of Cancer Research Center of Lyon (CRCL). He has performed research on preclinical onco-pharmacology with a particular interest in drug resistance as well as on nucleotide metabolism in cancer cell biology. Dr Jordheim brings his expertise in pharmacology, formulation and cell-based experiments to Antineo.